Zundelevich, A., Dadiani, M., Kahana-Edwin, S., Itay, A., Sella, T., Gadot, M., . . . Gal-Yam, E. N. (2020). ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast Cancer Research, 22(1), 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Zundelevich, Adi, et al. "ESR1 Mutations Are Frequent in Newly Diagnosed Metastatic and Loco-regional Recurrence of Endocrine-treated Breast Cancer and Carry Worse Prognosis."
Breast Cancer Research 22, no. 1 (2020): 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Zundelevich, Adi, et al. "ESR1 Mutations Are Frequent in Newly Diagnosed Metastatic and Loco-regional Recurrence of Endocrine-treated Breast Cancer and Carry Worse Prognosis."
Breast Cancer Research, vol. 22, no. 1, 2020, pp. 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.